|
[1]
|
Khoury MJ, Bowen MS, Clyne M, Dotson WD, Gwinn ML, Green RF, et al. From public health genomics to precision public health: A 20-year journey. Genet Med 2018;20(6):574 − 82. http://dx.doi.org/10.1038/gim.2017.211CrossRef
|
|
[2]
|
Weeramanthri TS, Dawkins HJS, Baynam G, Bellgard M, Gudes O, Semmens JB. Editorial: Precision public health. Front Public Health 2018;6:121. http://dx.doi.org/10.3389/fpubh.2018.00121CrossRef
|
|
[3]
|
Márquez-Luna C, Gazal S, Loh PR, Kim SS, Furlotte N, Auton A, et al. Incorporating functional priors improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. Nat Commun 2021;12(1):6052. http://dx.doi.org/10.1101/375337CrossRef
|
|
[4]
|
Shelton JF, Cameron B, Aslibekyan S, Gentleman R, 23andMe Research Team. Demographic, spatial and temporal dietary intake patterns among 526 774 23andMe research participants. Public Health Nutr 2021;24(10):2952 − 63. http://dx.doi.org/10.1017/S1368980020001251CrossRef
|
|
[5]
|
Guasch-Ferré M, Dashti HS, Merino J. Nutritional genomics and direct-to-consumer genetic testing: An overview. Adv Nutr 2018;9(2):128 − 35. http://dx.doi.org/10.1093/advances/nmy001CrossRef
|
|
[6]
|
Kang K, Sun X, Wang LZ, Yao XT, Tang SW, Deng JJ, et al. Direct-to-consumer genetic testing in China and its role in GWAS discovery and replication. Quant Biol 2021;9(2):201 − 15. http://dx.doi.org/10.1007/s40484-020-0209-2CrossRef
|
|
[7]
|
Roberts MC, Fohner AE, Landry L, Olstad DL, Smit AK, Turbitt E, et al. Advancing precision public health using human genomics: Examples from the field and future research opportunities. Genome Med 2021;13(1):97. http://dx.doi.org/10.1186/s13073-021-00911-0CrossRef
|
|
[8]
|
de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: A review of the literature. Health Econ 2012;21(2):145 − 72. http://dx.doi.org/10.1002/hec.1697CrossRef
|
|
[9]
|
Dearing JW, Cox JG. Diffusion of innovations theory, principles, and practice. Health Aff 2018;37(2):183 − 90. http://dx.doi.org/10.1377/hlthaff.2017.1104CrossRef
|
|
[10]
|
Zhou ZL, Su YF, Gao JM, Xu L, Zhang YG. New estimates of elasticity of demand for healthcare in rural China. Health Policy 2011;103(2 − 3):255 − 65. http://dx.doi.org/10.1016/j.healthpol.2011.09.005CrossRef
|
|
[11]
|
Gerdtham UG, Jönsson B. International comparisons of health expenditure: Theory, data and econometric analysis. Handb Health Econ 2000;1:11 − 53. http://dx.doi.org/10.1016/S1574-0064(00)80160-2CrossRef
|
|
[12]
|
Ramos E, Weissman SM. The dawn of consumer-directed testing. Am J Med Genet Part C: Semin Med Genet 2018;178(1):89 − 97. http://dx.doi.org/10.1002/ajmg.c.31603CrossRef
|
|
[13]
|
Burton H, Sagoo GS, Pharoah P, Zimmern RL. Time to revisit geoffrey rose: Strategies for prevention in the genomic era? Ital J Public Health 2012;9(4):e8665. http://dx.doi.org/10.2427/8665. |
|
[14]
|
Oh B. Direct-to-consumer genetic testing: Advantages and pitfalls. Genomics Inform 2019;17(3):e33. http://dx.doi.org/10.5808/GI.2019.17.3.e33CrossRef
|
|
[15]
|
Du L, Wang M. Genetic privacy and data protection: A review of chinese direct-to-consumer genetic test services. Front Genet 2020;11:416. http://dx.doi.org/10.3389/fgene.2020.00416CrossRef
|